Research programme: adenosine A2B receptor antagonists - Laboratorios AlmirallAlternative Names: LAS 38096
Latest Information Update: 16 Jul 2016
Price : $50 *
At a glance
- Originator Laboratorios Almirall
- Developer Almirall S.A.
- Class Furans; Pyrimidines
- Mechanism of Action Adenosine A2B receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Asthma in Spain